Catalyst Pharmaceuticals Inc
CPRX
$31.49+0.00%
End of day · as of Aug 25, 2026, 6:53 PM ET
Mkt cap
$3.84B
EV/Sales
5.32
P/E ratio
N/A
FY2025 Revenue
$588.99M
EPS (9mo ended 2025-09-30)
$1.27
Gross Margin (FY2025)
85.19%
Profit Margin (FY2025)
36.39%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Latest reported CPRX revenue for 2025-12-31 was $589.0M. Net income was $214.3M. Revenue was up 19.8% from 2024-12-31 to 2025-12-31. CPRX currently screens at market cap $3.84B.
Use this CPRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CPRX income, balance, and cash tables.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company in the Healthcare sector.
Latest cached Catalyst Pharmaceuticals Inc (CPRX) revenue for Dec 31, 2025 was $589.0M. Net income was $214.3M. Statements: https://lician.com/financials/cprx
Catalyst Pharmaceuticals Inc (CPRX) market capitalization is $3.84B on the latest cached snapshot.
Catalyst Pharmaceuticals Inc (CPRX) cached previous close $31.49; day range $31.48 – $31.51; volume 15,513,864. Session quote: https://lician.com/quote/cprx
Catalyst Pharmaceuticals Inc (CPRX) latest cached earnings event is "CPRX earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CPRX filing is 8-K · Jul 16, 2026. Filings: https://lician.com/sec/cprx